Tumors of the prostate
•
1-Primary into Benign & malignant.
•
2-Secondary involvement of the prostate occurs through
direct extension by carcinoma of the urinary bladder, urethra, colorectal ,
anus & soft tissue tumors.
•
Distant metastases have been seen from lung cancer
& melanoma.
Prostatic carcinoma
•
Most common form of cancer in men, Followed closely by
lung cancer.
•
Second leading cause of cancer death.
•
Approximately 70 % of men between 70-80 years have
prostatic carcinoma.
•
There are some remarkable & puzzling national
& racial differences in the incidence of this disease. These differences
are thought to be due to environmental influences.
Etiology:
•
Several risk factors e.g. age, race, family history,
hormone levels (testosterone & androgen) & environmental influences are
suspected of playing roles.
•
Increased consumption of fats has been implicated, its
influences the levels of hormones such as testosterone, which in turn affect
the growth of prostate.
•
Grossly: affecting peripheral zone of the gland
classically in the posterior location.
•
firm yellow
with gritty cut section
•
Histology: small closely packed glands (back-to-back)
with single cell lining. These cells have large vesicular nuclei with prominent
one or more nucleoli .Invasion of
capsule with its lymphatic & vascular channels, perineural invasion or
both.
Grading & staging:
•
Use Gleason’s grade. Grading particular importance
because there is in general fairly good correlation between the prognosis &
degree of differentiation.
Clinical course:
•
60 % of patient presented with localized disease in
the prostatic gland.
•
40
% of patient presented with invasion to the surrounded organ specially urinary
bladder & tract causing urinary symptoms or metastases by lymphatic to the
obturator lymph nodes.
•
Or metastasis by blood to the axial skeleton
especially to lumber spine, pelvis & thoracic spine producing osteoblastic
reaction.
Investigations:
•
PSA : increase in prostatic carcinoma usually more than 10
ng/ml
•
PAP : increase in cases with bony metastases
Treatment:
•
Surgery, radiotherapy & hormonal manipulation
prognosis:
•
depend on grading & staging but generally poor.
No comments:
Post a Comment